In December 2021, Antibody Engineering & Therapeutics hybrid conference took place online and in San Diego. Sessions exploring topics across antibody-based drug production were led by 135+ speakers from around the industry.
The comprehensive program boasted fascinating insights shared by the likes of Kristian Andersen (Scripps Research), James Wells (UCSF), Aviv Regev (Genentech Research & Early Development) and many more.
Join us as we take a look back at the highlights from the week, including the most captivating keynotes, the scientific poster presentation hall and reflective insights from AbCellera.
Click the image below or here to explore the report, or download a PDF version using the 'Download Now' link at the top of the page.